The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
出版年份 2018 全文链接
标题
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
作者
关键词
-
出版物
Blood Cancer Journal
Volume 8, Issue 2, Pages -
出版商
Springer Nature
发表日期
2018-02-10
DOI
10.1038/s41408-018-0054-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera
- (2017) Guilin Tang et al. HAEMATOLOGICA
- Frequency of polycythemia in individuals with normal complete blood cell counts according to the new 2016 WHO classification of myeloid neoplasms
- (2017) A. F. Sandes et al. International Journal of Laboratory Hematology
- Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders–A consensus project of the Italian Society of Hematology
- (2017) Paola Guglielmelli et al. LEUKEMIA RESEARCH
- Myeloproliferative Neoplasms
- (2017) Jerry L. Spivak NEW ENGLAND JOURNAL OF MEDICINE
- Myeloproliferative Neoplasms
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data
- (2017) Martin Schalling et al. Blood Cancer Journal
- Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera
- (2017) Guilin Tang et al. HAEMATOLOGICA
- Laboratory Investigation of Myeloproliferative Neoplasms (MPNs)
- (2016) Lambert Busque et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management
- (2016) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- LNK mutations and myeloproliferative disorders
- (2016) Mary Frances McMullin et al. AMERICAN JOURNAL OF HEMATOLOGY
- Myeloproliferative neoplasms: Morphology and clinical practice
- (2016) Tiziano Barbui et al. AMERICAN JOURNAL OF HEMATOLOGY
- Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms
- (2016) Elisa Rumi et al. BLOOD
- Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
- (2016) William Vainchenker et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances
- (2016) T. Barbui et al. BLOOD REVIEWS
- Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencing
- (2016) A Pardanani et al. LEUKEMIA
- The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations
- (2016) Umberto Gianelli et al. MODERN PATHOLOGY
- Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified
- (2016) Sa A Wang et al. MODERN PATHOLOGY
- Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients
- (2016) V De Stefano et al. Blood Cancer Journal
- WHO classification 2008 of myeloproliferative neoplasms: a workshop learning effect - the Danish experience
- (2015) Ann B. Madelung et al. APMIS
- Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms
- (2015) J. D. Milosevic Feenstra et al. BLOOD
- Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients
- (2015) X. Cabagnols et al. BLOOD
- Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes
- (2015) Alberto Alvarez-Larrán et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study
- (2015) Hans Michael Kvasnicka et al. HISTOPATHOLOGY
- Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria
- (2015) H Gisslinger et al. LEUKEMIA
- Circulating hematopoietic progenitor cells in essential thrombocythemia versus prefibrotic/early primary myelofibrosis
- (2014) Klaus Geissler et al. AMERICAN JOURNAL OF HEMATOLOGY
- Discriminating between essential thrombocythemia and masked polycythemia vera inJAK2mutated patients
- (2014) Tiziano Barbui et al. AMERICAN JOURNAL OF HEMATOLOGY
- Essential thrombocythemia vs. early/prefibrotic myelofibrosis: Why does it matter
- (2014) Giovanni Barosi BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants
- (2014) A. Tefferi et al. BLOOD
- Presence of calreticulin mutations in JAK2-negative polycythemia vera
- (2014) J. Broseus et al. BLOOD
- Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
- (2014) A. Tefferi et al. BLOOD
- Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012
- (2014) John T. Reilly et al. BRITISH JOURNAL OF HAEMATOLOGY
- WHO-histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes
- (2014) Alberto Alvarez-Larrán et al. BRITISH JOURNAL OF HAEMATOLOGY
- A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera
- (2014) Federico Lussana et al. BRITISH JOURNAL OF HAEMATOLOGY
- Calreticulin mutations and long-term survival in essential thrombocythemia
- (2014) A Tefferi et al. LEUKEMIA
- The importance of central pathology review in international trials: a comparison of local versus central bone marrow reticulin grading
- (2014) O Pozdnyakova et al. LEUKEMIA
- The rate of transformation from JAK2-mutated ET to PV is influenced by an accurate WHO-defined clinico-morphological diagnosis
- (2014) T Barbui et al. LEUKEMIA
- Age-related mutations associated with clonal hematopoietic expansion and malignancies
- (2014) Mingchao Xie et al. NATURE MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cooperation between pathologists and clinicians allows a better diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms
- (2014) Umberto Gianelli et al. Expert Review of Hematology
- World Health Organization-defined classification of myeloproliferative neoplasms: Morphological reproducibility and clinical correlations-The Danish experience
- (2013) Ann Brinch Madelung et al. AMERICAN JOURNAL OF HEMATOLOGY
- Masked polycythemia Vera (mPV): Results of an international study
- (2013) Tiziano Barbui et al. AMERICAN JOURNAL OF HEMATOLOGY
- Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis
- (2013) R. T. Silver et al. BLOOD
- Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia
- (2013) G. Rotunno et al. BLOOD
- JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
- (2013) E. Rumi et al. BLOOD
- Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial
- (2013) H. Gisslinger et al. BLOOD
- CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia
- (2013) A Pardanani et al. LEUKEMIA
- Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
- (2013) A Tefferi et al. LEUKEMIA
- Mutations and prognosis in primary myelofibrosis
- (2013) A M Vannucchi et al. LEUKEMIA
- Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: A consensus-based SIE, SIES, GITMO position paper
- (2013) Giovanni Barosi et al. LEUKEMIA RESEARCH
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML
- (2013) Julia E. Maxson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- WHO Classification of Myeloproliferative Neoplasms (MPN): A Critical Update
- (2013) Hans Michael Kvasnicka Current Hematologic Malignancy Reports
- Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome
- (2012) T. Barbui et al. BLOOD
- Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-up
- (2012) Elisabeth Ejerblad et al. Hematology
- Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
- (2012) Roberto Marchioli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis
- (2012) Giovanni Barosi et al. PLoS One
- Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia
- (2011) Alessandra Carobbio et al. AMERICAN JOURNAL OF HEMATOLOGY
- Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification
- (2011) J. Thiele et al. BLOOD
- Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations
- (2011) F. Passamonti et al. BLOOD
- Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria
- (2011) G Finazzi et al. LEUKEMIA
- The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera
- (2010) Khadija Abdulkarim et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis
- (2010) Maud Brousseau et al. HISTOPATHOLOGY
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients
- (2009) John M. Granger et al. CANCER
- The Significance of Bone Marrow Biopsy andJAK2V617FMutation in the Differential Diagnosis Between the “Early” Prepolycythemic Phase of Polycythemia Vera and Essential Thrombocythemia
- (2008) Umberto Gianelli et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started